5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb study

Por Hecht, J Randolph, Mitchell, Edith P, Yoshino, Takayuki, Welslau, Manfred, Lin, Xun, Chow Maneval, Edna, Paolini, Jolanda, Lechuga, Maria Jose, Kretzschmar, Albrecht
Publicado no Cancer Manag Res (2015)

Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib

Por Harmon, Charles S, DePrimo, Samuel E, Raymond, Eric, Cheng, Ann-Lii, Boucher, Eveline, Douillard, Jean-Yves, Lim, Ho Y, Kim, Jun S, Lechuga, Maria José, Lanzalone, Silvana, Lin, Xun, Faivre, Sandrine
Publicado em 2011

Clinical Outcomes of Patients with Advanced Gastrointestinal Stromal Tumors: Safety and Efficacy in a Worldwide Treatment-use Trial of Sunitinib

Por Reichardt, Peter, Kang, Yoon-Koo, Rutkowski, Piotr, Schuette, Jochen, Rosen, Lee S, Seddon, Beatrice, Yalcin, Suayib, Gelderblom, Hans, Williams, Charles C, Fumagalli, Elena, Biasco, Guido, Hurwitz, Herbert I, Kaiser, Pamela E, Fly, Kolette, Matczak, Ewa, Chen, Liang, Lechuga, Maria José, Demetri, George D
Publicado no Cancer (2015)

Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial

Por Reichardt, Peter, Demetri, George D., Gelderblom, Hans, Rutkowski, Piotr, Im, Seock-Ah, Gupta, Sudeep, Kang, Yoon-Koo, Schöffski, Patrick, Schuette, Jochen, Soulières, Denis, Blay, Jean-Yves, Goldstein, David, Fly, Kolette, Huang, Xin, Corsaro, Massimo, Lechuga, Maria Jose, Martini, Jean-Francois, Heinrich, Michael C.
Publicado no BMC Cancer (2016)